Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462961 | 12646296 | 1 | I | 20141206 | 20160803 | 20160812 | 20160812 | EXP | CN-009507513-1608CHN003566 | MERCK | 15.00 | YR | F | Y | 51.00000 | KG | 20160812 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462961 | 12646296 | 1 | PS | INTRON A | INTERFERON ALFA-2B | 1 | 11 MILLION IU, UNK | 103132 | 11 | MIU | SOLUTION FOR INJECTION | ||||||||
| 126462961 | 12646296 | 2 | SS | INTRON A | INTERFERON ALFA-2B | 1 | ON THE 2ND, 3RD AND 4TH WEEK THE DOSAGE WAS GRADUALLY INCREASED TO 28 MILLION IU | 103132 | SOLUTION FOR INJECTION | ||||||||||
| 126462961 | 12646296 | 3 | SS | INTRON A | INTERFERON ALFA-2B | 1 | Intramuscular | 11.5 MILLION IU, UNK | 103132 | 11.5 | MIU | SOLUTION FOR INJECTION | |||||||
| 126462961 | 12646296 | 4 | SS | INTRON A | INTERFERON ALFA-2B | 1 | 14 MILLION IU, UNK | 103132 | 14 | MIU | SOLUTION FOR INJECTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126462961 | 12646296 | 1 | Malignant melanoma stage II |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126462961 | 12646296 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126462961 | 12646296 | Drug administered to patient of inappropriate age | |
| 126462961 | 12646296 | Metastases to lymph nodes | |
| 126462961 | 12646296 | N-ras gene mutation | |
| 126462961 | 12646296 | Neoplasm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126462961 | 12646296 | 1 | 20141206 | 20141212 | 0 | |
| 126462961 | 12646296 | 2 | 20141213 | 20150102 | 0 | |
| 126462961 | 12646296 | 3 | 201501 | 201512 | 0 | |
| 126462961 | 12646296 | 4 | 201604 | 201606 | 0 |